DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $31.00 at Robert W. Baird

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target lowered by Robert W. Baird from $33.00 to $31.00 in a report published on Monday, Benzinga reports. The firm currently has a neutral rating on the medical instruments supplier’s stock.

Other equities research analysts have also recently issued research reports about the stock. Stifel Nicolaus dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating on the stock in a research note on Thursday, July 18th. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating on the stock in a research note on Tuesday, July 9th. The Goldman Sachs Group dropped their price objective on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating on the stock in a research note on Monday, May 6th. Piper Sandler reissued a neutral rating and issued a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Finally, Barrington Research reissued an outperform rating and issued a $38.00 price target on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average target price of $33.67.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $26.24 on Monday. DENTSPLY SIRONA has a twelve month low of $23.94 and a twelve month high of $41.65. The company’s 50 day moving average is $26.43 and its 200 day moving average is $30.55. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The company has a market cap of $5.45 billion, a PE ratio of -59.64, a price-to-earnings-growth ratio of 1.18 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business’s revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the company earned $0.39 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA will post 2.02 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 2.44%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 3,577 shares of the firm’s stock in a transaction on Friday, May 31st. The shares were bought at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Bar Harbor Wealth Management purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $4,931,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 44.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock valued at $4,684,000 after buying an additional 43,230 shares during the period. Illinois Municipal Retirement Fund raised its holdings in DENTSPLY SIRONA by 369.9% in the 1st quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock valued at $4,102,000 after buying an additional 97,281 shares during the period. Intech Investment Management LLC purchased a new stake in DENTSPLY SIRONA in the 1st quarter valued at about $1,202,000. Finally, Duality Advisers LP purchased a new stake in DENTSPLY SIRONA in the 1st quarter valued at about $1,166,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.